Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators

E L Ochoa1, A Chattopadhyay, M G McNamee

  • 1Department of Biochemistry and Biophysics, University of California, Davis 95616.

Insights

Desensitization, a loss of response to stimuli, affects nicotinic acetylcholine receptors. This specific process, crucial for neuronal function and potentially linked to diseases like myasthenia gravis, involves receptor inactivation and affinity changes.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Desensitization is a general biological term for loss of response to stimuli.
  • Specific desensitization of nicotinic acetylcholine receptors (nAChRs) involves ion channel inactivation.
  • nAChR desensitization, first described in 1957, is an intrinsic receptor property.

Purpose of the Study:

  • To review the mechanisms and modulators of nicotinic acetylcholine receptor desensitization.
  • To discuss the potential physiological and pathological significance of nAChR desensitization.

Main Methods:

  • Analysis of rapid kinetic techniques and single-channel recordings.
  • Spectroscopic and kinetic studies to detect conformational changes.
  • Review of literature on nAChR desensitization modulators and mechanisms.

Main Results:

  • nAChR desensitization involves increased agonist affinity and conformational changes.
  • A four-state model explains key experimental observations.
  • Various substances and covalent modifications, like phosphorylation, can modulate nAChR desensitization.

Conclusions:

  • The precise molecular mechanism of nAChR desensitization requires further elucidation.
  • nAChR desensitization may play a role in memory, learning, and neuromuscular diseases such as myasthenia gravis.

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...